Trial begins for world-first multivariant COVID-19 vaccine booster
A phase one trial for the world’s first multivariant COVID-19 booster vaccine has been launched in Manchester.
Initiated by pharmaceutical company Gritstone, in partnership with...
Analysis of enzyme could improve Alzheimer’s and cancer treatment
Advancement in treatment for Alzheimer's disease and cancer could be on the horizon thanks to a novel investigation of the meprin β enzyme.
Researchers from...
XPhyto Therapeutics’ biosensors: taking rapid testing to the next level
Testing for coronaviruses may soon take no more than a couple of minutes thanks to XPhyto’s enzyme-based biosensor diagnostic technology.
A Canadian-headquartered life sciences company...
Reducing resistance to cancer immunotherapy with groundbreaking lipid
A team of Japanese scientists has potentially discovered an innovative method to reduce a patient’s resistance to cancer immunotherapy.
The team, based at the Hokkaido...
Enhancing vaccine design with B lymphocytes discovery
Findings from a research study of B lymphocytes – otherwise known as B cells – may aid in advancing the design of future vaccines.
The...
Improving leukaemia therapy through targeted treatment
Researchers at the University of Basel have demonstrated an effective method of targeted treatment to enhance leukaemia therapy.
New communication discovered between human embryos and mother
A team of scientists based in the UK have identified an exciting new method in which human embryos interact with their mother-to-be.
The team, comprised...
Defence Therapeutics’ new COVID vaccine achieves successful testing
Biotechnology experts Defence Therapeutics have sensationally announced that their new COVID vaccine has demonstrated effectiveness in a non-rodent model.
The new COVID vaccine – called...
Ensuring the future of the NHS with revolutionary health innovations
Lorna Green, the Director of Enterprise and Growth at Innovation Agency, part of the Academic Health Science Network, speaks about how health innovations are...
Risk of dementia significantly exacerbated by eye conditions
A novel study has indicated that a plethora of eye conditions may potentially increase the risk of developing dementia.
The research, published in the British...
Health experts believe COVID-19 booster vaccines are not yet required
A group of industry-leading health experts has concluded that COVID-19 booster vaccines are not yet needed to combat the pandemic.
The international team of scientists,...
Innovative wound healing that utilises the body’s own defence system
Colzyx is developing a new generation of bioactive wound dressing that accelerates healing and combats infections, including those that are multi-drug resistant.
A novel medical...
Exploring the benefits of waterless bathing products
Infection prevention company GAMA Healthcare explains how innovative waterless bathing products could help to reduce the risk of infection transmission, improve patient care, and...
Commonly prescribed gout medication found effective against COVID-19
A conventional gout medication that is utilised widely around the world has proven to be effective at combatting COVID-19, potentially adding a new weapon...
The use of the balance quotient in sport-related concussion
Matti Vartiainen from Ainone discusses a pilot study designed to identify balance quotient values for the baseline of athletes’ performance.
The ability to maintain postural...
Combatting the pandemic of chronic wounds with Debrichem®
As COVID-19 shifted attention and medical resources from the community, chronic wounds are causing a pandemic of their own. However, DEBX Medical’s Debrichem® aims...
The Environmental Protection Agency: Safeguarding public health
The United States Environmental Protection Agency has a key role to play in ensuring only safe products reach the market, something of increasing importance...
Innovative smart cup tackles the effects of dehydration in care homes
Aquarate explain the life-threatening effects of dehydration and introduce their Hydracup, aimed at improving quality of care for loved ones.
Britain’s ageing population is increasing....
Defence Therapeutics unveil novel HPV vaccine development programme
Industry-leading biotechnology company Defence Therapeutics has revealed that it will be establishing a high priority programme to develop a new HPV vaccine for cervical...
AI could speed up lung cancer diagnosis by a year
Scientists have developed an Artificial Intelligence (AI) screening method that they say could detect signs of lung cancer on CT scans a year faster...